We herein describe two patients with a prolonged disturbance of consciousness due to severe hypophosphatemia. Case one presented with pneumococcal infection and acute exacerbation of chronic obstructive pulmonary disease and asthma. Case two presented with diabetic foot infections and diabetic ketoacidosis. Both patients responded to initial therapy for their primary diseases, but consciousness became worse in both cases. Their test results for impaired consciousness revealed severe hypophosphatemia; therefore, phosphate replacement therapy was administered, thus resulting in complete alertness. These cases demonstrate that we should consider the possibility of hypophosphatemia in critically ill patients with an altered consciousness.
Introduction
Phosphate plays a critical role in regulating various essential biological functions, and phosphorus-containing compounds are components of cellular membranes, nucleic acids, and nucleoproteins that act as acid-base homeostasis regulators and play important roles in post-receptor signaling and energy transfer through phosphorylation or ATP generation (1) (2) (3) (4) . Therefore, hypophosphatemia can result in dysregulation of respiratory, cardiac, hematologic, musculoskeletal, renal, and central nervous system functions, thereby causing considerable morbidity and increased mortality (2, 4) .
In general, hypophosphatemia may be categorized as severe (<1.0 mg/dL), moderate (1.0-2.0 mg/dL), or mild (approximately 2.1-2.5 mg/dL) (1) . The incidence of severe hypophosphatemia is reportedly 0.43% among hospitalized patients (2, 3) .
The diagnosis of hypophosphatemia is usually missed because of nonspecific signs and symptoms, and serum phosphorus level is not routinely examined in clinical set-tings (4) . For example, various common medical therapies against many diseases, such as parenteral nutrition therapy and the use of beta-adrenergic agonists, glucocorticoids, and catecholamines, induce or exacerbate hypophosphatemia in critically ill patients (1, 3) . Unless physicians recognize the possibility of hypophosphatemia in their patients and understand the effects of therapeutic agents on phosphorus regulation, promising initial treatments might cause severe hypophosphatemia and lead to unfavorable outcomes.
We herein describe two cases of severe hypophosphatemia with a progressive disturbance of consciousness even though both cases seemed to respond successfully to the initial therapies. P: alkaline phosphatase, PT-INR: prothorombin time-international normalized ratio, APTT: activated partial thromboplastin time, ABG: arterial blood gas, PCO2: partial pressure of carbon dioxide, PO2: partial pressure oxygen, HCO3: bicarbonate, BE: base excess, free T3: free triiodothyronine, free T4: free total thyroxine, TSH: thyroid stimulating hormone, Intact PTH: intact parathyroid hormone ent regional medical center one day before her referral. She had no family history of bone or mineral metabolism disorders. She did not follow any dietary restrictions and denied both alcohol consumption and current smoking. Her past history revealed asthma at 58 years of age and COPD at 60 years of age, which was being treated with the twice-daily inhalation of 250 μg fluticasone/50 μg salmeterol and home oxygen therapy at a flow rate of 2 L/min. She exhibited wheezing and hypoxemia on her initial presentation to the first medical center (saturation of peripheral blood oxygen of 96% while breathing 32% oxygen), where a diagnosis of acute exacerbation of COPD and asthma was made. Although salbutamol sulfate inhalation and 100 mg hydrocortisone and 250 mg aminophylline daily infusions were administered, her respiratory status worsened, and she was transferred to our hospital the next day.
The patient was unconscious on admission. A preliminary evaluation revealed a Glasgow Coma Scale (GCS) score of 10; temperature, 37.9 ; pulse, 132 beats per min; saturation of peripheral blood oxygen while breathing 32% oxygen, 90%; and blood pressure, 169/101 mmHg. There were no remarkable findings on the physical examination except for purulent sputum and scattered wheezing. A chest X-ray film revealed no abnormalities. The results from a pneumococcal urinary antigen test (Binax NOW ; Binax, Inc., Portland, USA) were positive. A sputum culture yielded Streptococcus pneumoniae. Her laboratory test results obtained on admission revealed mild hypophosphatemia (2.2 mg/dL; normal range, 2.5-4.5 mg/dL) and evident hypercapnia and respiratory acidosis ( Table 1 ). These results indicated that her altered consciousness may have been primarily due to carbon dioxide narcosis in addition to pneumococcal respiratory infection diagnosis and established acute exacerbation of COPD and asthma. Therapy with noninvasive positivepressure ventilation (NPPV) and intravenous (i.v.) ampicillin/sulbactam and hydrocortisone (800 mg/day) infusions were started immediately. Although salbutamol sulfate inhalations were planned, the patient was noncompliant because of her altered consciousness. On day two, we added daily 550-mg acetazolamide sodium infusions. We initiated peripheral nutrition support without phosphorus supplementation due to her poor oral intake. Despite the fact that the infection was well controlled, her hypercapnia and respiratory acidosis only gradually improved. On day four, arterial blood gas (ABG) analysis performed while the patient breathed 40% oxygen revealed a partial pressure of carbon dioxide at 61.9 mmHg and a pH of 7.35. However, her mental status continued to worsen. On day four, her GCS score was seven. Head computed tomography (CT) and magnetic resonance imaging (MRI) of the brain revealed no significant findings. Laboratory test results (Table 1) showed mild hyperammonemia and severe hypophosphatemia (0.6 mg/dL); however, the mild hyperammonemia seemed to originate from acetazolamide administration and was not the primary cause of altered consciousness because she did not present with a flapping tremor and there was no indication of liver damage. On the other hand, her severe hypophosphatemia rapidly progressed. The patient's blood test results also revealed a vitamin D deficiency and relative hypoparathyroidism ( Table 1 ). The renal phosphate threshold normalized for the glomerular filtration rate (Tmp/GFR) on day four was extremely low (0.5 mg/100 mL; normal range, 2.5-4.2 mg/100 mL) because of increased urinary phosphorus excretion (5) . The severity of her hypophosphatemia was found to be consistent with that of her altered level of consciousness ( Fig. 1 ). Therefore, on day five, we started i.v. phosphate replacement therapy with 2.5 mM/day of sodium dihydrogen phosphate dehydrate, which was continued for four days. On day five, acetazolamide was discontinued. We tapered hydrocortisone infusion on the same day and discontinued it altogether on day eight. Her serum phosphorus level steadily improved from 1.5 mg/dL on day six to 3.2 mg/dL on day nine. Her Tmp/GFR level was also successfully restored to normal (3.1 mg/100 mL) on day nine, which was the day after hydrocortisone withdrawal. At the same time, the patient's consciousness was fully recovered (Fig. 1 ). Her GCS score was 13 on day six and 15 on day nine. She was weaned from NPPV on day eight and initiated oral intake on day 9. Her intact-parathyroid hormone (PTH) level improved to 28 pg/mL with normal levels of serum corrected calcium (9.1 mg/dL) and phosphorus (3.6 mg/ dL) on day 11. P: alkaline phosphatase, HbA1c: hemoglobin A1c, anti-GAD antibody: anti-glutamate decarboxylase autoantibodies, free T3: free triiodothyronine, free T4: free total thyroxine, TSH: thyroid stimulating hormone, PT-INR: prothorombin time-international normalized ratio, APTT: activated partial thromboplastin time, FDP: fibrinogen/fibrin degradation products, HPF: high-power field, ABG: arterial blood gas, PCO2: partial pressure of carbon dioxide, PO2: partial pressure oxygen, HCO3: bicarbonate, BE: base excess
Case 2
A 72-year-old woman was referred to our hospital because of diabetic ketoacidosis (DKA), hypothermia, and diabetic foot infections. She developed redness of her right leg two days before referral and experienced emesis and paradipsia on admission to a different regional medical center one day before referral, where she developed shock. Thereafter, she was transferred to our hospital for further evaluation and treatment. She had no family history of bone or mineral metabolism disorders and did not follow any dietary restrictions and denied any alcohol consumption. Her past history revealed a 10-year history of untreated diabetes mellitus and hypertension.
The patient was semi-conscious on admission. Her GCS score was 13; height, 155 cm; weight, 64.0 kg; axillary temperature, 30.3 ; pulse, 56 beats per min; saturation of peripheral blood oxygen, 96% (room air); and blood pressure, 71/43 mmHg. A physical examination revealed hyperpnea, poor skin turgor, and right leg cellulitis. There were no other significant abnormalities. The laboratory test results obtained on admission revealed hyperglycemia with metabolic acidosis and urine ketone excretion (Table 2) . Thus, the patient was diagnosed with DKA with diabetic foot infections and hypothermia. We immediately initiated therapeutic procedures with rewarming strategies and infusions of normal saline (1 L/h), dopamine (5 γ), meropenem, and continuous i.v. insulin. The infusion solution did not include phosphorus. Her deep body temperature increased to normal, and her blood pressure stabilized. The levels of hyperglycemia and metabolic acidosis improved at an appropriate rate, but she continued to exhibit altered consciousness. On day two, her GCS score was seven. Head CT and MRI of the brain showed no significant findings. The results of a cere- Fig. 2 ). The Tmp/GFR level was also successfully restored (1.5 mg/100 mL on day three, 1.9 mg/100 mL on day eight, and 3.0 mg/100 mL on day 12). At the same time, her consciousness level improved (Fig. 2) . On day three, just 8 h after starting phosphate replacement, her GCS score rapidly increased to 10, and a full recovery of her mental status was observed on day five.
Discussion
Hypophosphatemia is not uncommon and is observed in 1-5% of the general medication population (1) . Hypophosphatemia can lead to the onset of rhabdomyolysis, hemolysis, leukocyte dysfunction, respiratory failure, impaired myocardial performance, and impaired central nervous system function. However, these clinical sequelae are generally limited to severe hypophosphatemia cases. Despite the prevalence of hypophosphatemia, severe hypophosphatemia and its clinical consequences are rarely encountered (1) (2) (3) (4) .
Hypophosphatemia often goes undiagnosed because affected patients initially present with nonspecific symptoms, and serum phosphorus levels are rarely examined (1). In the two cases described herein, hypophosphatemia was detected after deteriorated consciousness. Hypophosphatemia can cause life-threatening consequences, and severe hypophosphatemia is reportedly associated with a four-fold increase in mortality (6) . It is therefore important to emphasize the early recognition and treatment of severe hypophosphatemia.
There are relatively few case reports in the literature indicating an association between hypophosphatemia and various central neurological disorders, including coma (1-4, 7-10). All previously reported coma cases were in patients with severe hypophosphatemia. For example, Mégarbane et al. (10) described a DKA case with severe hypophosphatemia and coma in which an electroencephalo-gram showed bilateral spikes with a background theta wave rhythm, and they found that phosphate repletion improved the abnormal electroencephalogram finding and mental status of their patient. These findings indicate that hypophosphatemia can directly impair the cerebral electrophysiological activity and alter consciousness. Therefore, we should recognize the possibility of hypophosphatemia as a cause of coma.
The serum phosphorus concentration is determined by several factors, including decreased dietary intake, redistribution, and increased urinary phosphorus excretion. Although critically ill patients usually have poor nutrition, it is rare for decreased dietary intake alone to induce severe hypophosphatemia (2) . However, various diseases and medical therapies might affect redistribution or increase urinary phosphorus excretion (4) . Moreover, multiple medical treatments are often administered to critically ill patients over a relatively short period. Thus, despite whether the initial treatment achieves promising results, a possible induction of acute severe hypophosphatemia should be considered in such patients.
In our first case, acute severe hypophosphatemia with an extremely low Tmp/GFR was observed despite improvements in hypercapnia and respiratory acidosis (Fig. 1) . After admission, the patient's hydrocortisone dose was increased, and acetazolamide was initiated. Correction of respiratory acidosis, which stimulates the glycolytic pathway and phosphorus uptake by muscle tissue, can cause hypophosphatemia secondary to phosphorus intracellular shifts (2) . Acetazolamide is an effective phosphaturic diuretic (3), and glucocorticoid therapy increases urinary phosphate losses through reduced reabsorption in the proximal tubules (3, 11) . The patient's Tmp/GFR level was restored the day after hydrocortisone withdrawal and four days after acetazolamide withdrawal, indicating that hydrocortisone and/or acetazolamide might induce urinary phosphorus excretion, which was one of the primary factors of hypophosphatemia in this case. Therefore, we should note the necessity of monitoring serum phosphorus level in patients treated with glucocorticoids and/or acetazolamide. In addition, vitamin D deficiency also contributed to hypophosphatemia and should be considered an exacerbation factor of severe hypophosphatemia. In this case, relative hypoparathyroidism was observed (Table 1) , which could have been caused by severe acidosis, a low-normal level of serum albumin, and a relative high level of ionized calcium, as well as by severe hypophosphatemia due to her improved PTH level on day 11. However, the possibility of primary hypoparathyroidism or calcium-sensing receptor abnormalities was not completely ruled out.
Our second case also developed acute hypophosphatemia with DKA despite improvement in acid-base disturbances and glucose levels (Fig. 2) . In patients with DKA, renal phosphate excretion is increased during the early stages of symptom onset (2, 12) . Moreover, transcellular phosphorus shifts are attributed to fluid resuscitation and insulin ther- (3, 12) . In addition, a high fluid administration rate (1 L/h) is reportedly a risk factor of hypophosphatemia (13) . Thus, phosphate redistribution caused by fluid resuscitation and insulin therapy seemed to have been two of the primary factors underlying hypophosphatemia in case two. On the other hand, her Tmp/GFR level remained low at the early stage of symptom onset. This is notable as the patient's initial phosphaturia should have decreased after ketoacidosis correction, and it could be due to dopamine administration as dopamine was previously demonstrated to have a phosphaturic effect at 0.25-8.0 γ infusion (3, 14) . In fact, after dopamine withdrawal, case two did not require additional i.v. phosphate replacement therapy. As previously shown in DKA (2, 3, (12) (13) (14) , the level of serum phosphate was rapidly changed, as were those of pH, blood glucose, and potassium in case two ( Table 2, 3) . Therefore, we should reaffirm the importance of the routine and regular monitoring of serum phosphorus and potassium levels during DKA therapy.
Both cases one and two achieved full recovery of consciousness after i.v. phosphate replacement therapy. This in itself supports the hypothesis that severe hypophosphatemia caused their prolonged altered consciousness. Severe hypophosphatemia in critically ill patients should be treated by i.v. phosphate replacement therapy because routine phosphate supplementation is not efficacious to all patients with DKA (1, 2, 15, 16) . At the same time, it is emphasized that hypophosphatemia in patients with COPD or DKA should be regularly monitored and adequately treated to avoid the clinical manifestations of severe hypophosphatemia. Potassium acid phosphate is usually used as a phosphate solution. Although we used a sodium-based phosphate preparation because potassium acid phosphate was unavailable in our hos-pital, it was found to be safe and effective.
We herein reported two patients with prolonged consciousness disturbance due to severe hypophosphatemia. Physicians should therefore recognize the possibility of hypophosphatemia in patients with altered consciousness and understand the effects of therapeutic agents on phosphorus regulation in critically ill patients.
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